National Health Investors (NHI) Cash & Equivalents (2009 - 2026)

National Health Investors' Cash & Equivalents history runs 18 years deep, the most recent figure standing at $24.9 million for Q1 2026.

• Quarterly Cash & Equivalents fell 81.52% year-over-year to $24.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.9 million (down 81.52% YoY) and the FY2025 annual result came in at $19.6 million, down 19.21% from the prior year.
• Cash & Equivalents was $24.9 million for Q1 2026 at National Health Investors, up from $19.6 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $135.0 million in Q1 2025 and bottomed at $11.4 million in Q1 2024.
• A 5-year average of $32.0 million and a median of $19.6 million in 2025 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2025 — Cash & Equivalents jumped 1088.73% — and 2026, when it slumped 81.52%.
• National Health Investors' Cash & Equivalents stood at $19.3 million in 2022, then increased by 15.84% to $22.3 million in 2023, then rose by 8.69% to $24.3 million in 2024, then dropped by 19.21% to $19.6 million in 2025, then climbed by 27.13% to $24.9 million in 2026.
• Business Quant data shows NHI's Cash & Equivalents at $24.9 million in Q1 2026, $19.6 million in Q4 2025, and $81.6 million in Q3 2025.